POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_C_EU7C101_0 (MATRIX PROTEIN 2)	1ijt	FIBROBLAST GROWTH FACTOR 4 (Homo sapiens)	5 / 9	SER A 194 ALA A 168 VAL A 199 ALA A 180 GLY A 190	None	1.15A	10.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_C_EU7C101_0 (MATRIX PROTEIN 2)	2a8i	THREONINE ASPARTASE 1 (Homo sapiens)	5 / 9	ALA A 101 ALA A 266 SER A 251 VAL A 130 GLY A 264	None	1.15A	4.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_C_EU7C101_0 (MATRIX PROTEIN 2)	2f9q	CYTOCHROME P450 2D6 (Homo sapiens)	5 / 9	ALA A 127 SER A 289 VAL A 119 ALA A 122 VAL A 298	None None HEM  A 600 (-4.6A) None None	0.98A	4.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_C_EU7C101_0 (MATRIX PROTEIN 2)	2ibu	ACETYL-COA ACETYLTRANSFERASE (Homo sapiens)	5 / 9	ALA A 333 ALA A 410 SER A 411 VAL A 374 GLY A 408	None	1.17A	3.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_C_EU7C101_0 (MATRIX PROTEIN 2)	4kxb	GLUTAMYL AMINOPEPTIDASE (Homo sapiens)	5 / 9	ALA A 419 SER A 420 VAL A 390 ALA A 392 GLY A 426	ZN  A1001 ( 4.2A) None BES  A1017 ( 3.7A) None None	1.10A	3.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_C_EU7C101_0 (MATRIX PROTEIN 2)	4xib	E3 UBIQUITIN-PROTEIN LIGASE MIB1 (Homo sapiens)	5 / 9	SER A 213 VAL A  49 SER A  41 VAL A  51 GLY A  15	None	1.23A	7.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_C_EU7C101_0 (MATRIX PROTEIN 2)	5lf9	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 22 (Homo sapiens)	5 / 9	SER A 275 VAL A 123 ALA A 222 SER A 221 GLY A 209	None	1.24A	6.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_C_EU7C101_0 (MATRIX PROTEIN 2)	5ulm	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5 (Homo sapiens)	5 / 9	VAL A 494 ALA A 497 SER A 498 VAL A 486 GLY A 479	None	1.03A	5.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_C_EU7C101_0 (MATRIX PROTEIN 2)	5zya	SPLICING FACTOR 3B SUBUNIT 1 (Homo sapiens)	5 / 9	ALA C 601 VAL C 634 ALA C 636 SER C 637 GLY C 640	None	1.16A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_C_EU7C101_0 (MATRIX PROTEIN 2)	6eti	ATP-BINDING CASSETTE SUB-FAMILY G MEMBER 2 (Homo sapiens)	5 / 9	SER A 440 ALA A 444 SER A 443 ALA A 520 SER A 521	None	0.89A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	2d8i	T-CELL LYMPHOMA INVASION AND METASTASIS 1 VARIANT (Homo sapiens)	5 / 9	ALA A  64 SER A  50 ALA A  57 SER A  58 GLY A  61	None	1.20A	15.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	2eyz	V-CRK SARCOMA VIRUS CT10 ONCOGENE HOMOLOG ISOFORM A (Homo sapiens)	5 / 9	SER A  43 SER A  83 GLY A  81 SER A  85 GLY A  66	None	1.20A	6.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	2j6l	ALDEHYDE DEHYDROGENASE FAMILY 7 MEMBER A1 (Homo sapiens)	5 / 9	ALA A 233 GLY A 231 ALA A  56 GLY A 226 SER A  57	None NAI  A1501 (-3.4A) None None None	1.19A	6.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	2qqk	NEUROPILIN-2 (Homo sapiens)	5 / 9	ALA A 390 ALA A 419 GLY A 346 GLY A 317 SER A 349	None	1.12A	3.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	2qqo	NEUROPILIN-2 (Homo sapiens)	5 / 9	ALA A 390 ALA A 419 GLY A 346 GLY A 317 SER A 349	None TRS  A 602 ( 4.7A) None None None	1.12A	4.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	3hhd	FATTY ACID SYNTHASE (Homo sapiens)	5 / 9	ALA A 340 ALA A 292 ALA A 214 GLY A 294 SER A 327	None	1.18A	2.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	3ihj	ALANINE AMINOTRANSFERASE 2 (Homo sapiens)	5 / 9	ALA A 187 SER A 338 GLY A 352 SER A 188 GLY A 190	PLP  A   1 (-3.6A) PLP  A   1 (-2.6A) None PLP  A   1 (-2.7A) None	1.19A	5.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	3snh	DYNAMIN-1 (Homo sapiens)	5 / 9	ALA A  42 SER A  41 ALA A 186 GLY A  38 SER A 184	None	1.22A	2.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	3snh	DYNAMIN-1 (Homo sapiens)	5 / 9	ALA A  42 SER A  41 ALA A 186 GLY A  38 SER A 184	None	1.22A	2.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	3v30	DNA-BINDING PROTEIN RFXANK (Homo sapiens)	5 / 9	ALA A 208 ALA A 197 ALA A 164 SER A 165 GLY A 168	None	1.11A	9.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	4m9p	FILAMIN-A (Homo sapiens)	5 / 9	ALA A 595 SER A 594 GLY A 589 SER A 748 GLY A 750	None	1.14A	7.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	4qdr	NEUROPILIN-2 (Homo sapiens)	5 / 9	ALA A 390 ALA A 419 GLY A 346 GLY A 317 SER A 349	None	1.17A	6.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	4rg1	C9ORF114 (Homo sapiens)	5 / 9	ALA A 323 GLY A 320 ALA A 272 SER A 271 SER A 268	None	1.04A	5.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	4wgk	NEUTRAL CERAMIDASE (Homo sapiens)	5 / 9	ALA A 344 ALA A 141 ALA A 109 SER A 230 GLY A 107	None	1.22A	3.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	5dn2	NEUROPILIN-2 (Homo sapiens)	5 / 9	ALA A 390 ALA A 419 GLY A 346 GLY A 317 SER A 349	None	1.15A	11.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	6eti	ATP-BINDING CASSETTE SUB-FAMILY G MEMBER 2 (Homo sapiens)	5 / 9	ALA A 444 SER A 443 ALA A 520 SER A 521 SER A 440	None	0.86A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	6eti	ATP-BINDING CASSETTE SUB-FAMILY G MEMBER 2 (Homo sapiens)	5 / 9	SER A 440 ALA A 444 SER A 443 ALA A 520 SER A 521	None	0.91A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BOC_A_EU7A102_0 (MATRIX PROTEIN 2)	1wao	SERINE/THREONINE PROTEIN PHOSPHATASE 5 (Homo sapiens)	4 / 6	ALA 1  81 SER 1  69 ALA 1 104 SER 1 105	None	1.00A	4.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BOC_A_EU7A102_0 (MATRIX PROTEIN 2)	2bug	SERINE/THREONINE PROTEIN PHOSPHATASE 5 (Homo sapiens)	4 / 6	ALA A  81 SER A  69 ALA A 104 SER A 105	None	0.81A	13.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BOC_A_EU7A102_0 (MATRIX PROTEIN 2)	2vn8	RETICULON-4-INTERACT ING PROTEIN 1 (Homo sapiens)	4 / 6	ALA A 240 SER A 237 ALA A 213 SER A 214	None NDP  A 600 (-3.0A) None NDP  A 600 (-2.7A)	1.05A	7.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BOC_A_EU7A102_0 (MATRIX PROTEIN 2)	3qt2	INTERLEUKIN-5 RECEPTOR SUBUNIT ALPHA (Homo sapiens)	4 / 6	SER A  77 ALA A  51 ALA A  76 SER A  75	BGC  A 317 (-3.6A) None None None	1.05A	4.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BOC_A_EU7A102_0 (MATRIX PROTEIN 2)	4lg8	PRE-MRNA-PROCESSING FACTOR 19 (Homo sapiens)	4 / 6	SER A 492 SER A 498 ALA A 211 SER A 212	None	1.03A	6.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BOC_A_EU7A102_0 (MATRIX PROTEIN 2)	5nug	CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1 (Homo sapiens)	4 / 6	SER A3002 ALA A3080 ALA A2625 SER A2624	None	0.96A	0.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BOC_A_EU7A102_0 (MATRIX PROTEIN 2)	5y3r	DNA-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT (Homo sapiens)	4 / 6	SER C1657 ALA C1680 SER C1677 ALA C1650	None	1.03A	0.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BOC_A_EU7A102_0 (MATRIX PROTEIN 2)	6eti	ATP-BINDING CASSETTE SUB-FAMILY G MEMBER 2 (Homo sapiens)	5 / 6	SER A 440 ALA A 444 SER A 443 ALA A 520 SER A 521	None	0.90A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BOC_A_EU7A102_0 (MATRIX PROTEIN 2)	6eti	ATP-BINDING CASSETTE SUB-FAMILY G MEMBER 2 (Homo sapiens)	4 / 6	SER A 440 SER A 443 ALA A 520 SER A 521	None	0.93A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BOC_A_EU7A102_0 (MATRIX PROTEIN 2)	6eti	ATP-BINDING CASSETTE SUB-FAMILY G MEMBER 2 (Homo sapiens)	4 / 6	SER A 521 SER A 440 ALA A 444 SER A 443	None	0.91A	undetectable